Valuation Cipher Pharmaceuticals Inc.

Stocks

Market Closed - Toronto S.E. 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
13.05 ^CAD	-3.33%		-2.54%	-13.35%

09-21	Cipher Pharmaceuticals Inc. Announces Appointment of Rajiv De Silva to Board of Directors, Effective September 21, 2026	CI
09-01	Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	46.45	96.48	133.1	366.4	382.2	331.7	-	-
Change	-	107.72%	37.94%	175.35%	4.29%	-13.22%	-	-
Enterprise Value (EV)	46.45	96.48	133.1	366.4	382.2	331.7	331.7	331.7
Change	-	107.72%	37.94%	175.35%	4.29%	-13.22%	0%	0%
P/E	4.83x	2.71x	5.12x	21.8x	10.5x	11.6x	10.8x	10.4x
PBR	0.93x	1.11x	1.29x	2.47x	2.23x	1.62x	1.39x	1.21x
PEG	-	0x	-0.2x	-0.6x	0x	-0.5x	1.35x	2.95x
Capitalization / Revenue	1.67x	3.39x	4.65x	7.68x	5.56x	4.68x	4.08x	3.87x
EV / Revenue	0x	0x	0x	0x	0x	4.68x	4.08x	3.87x
EV / EBITDA	0x	0x	0x	0x	0x	8.04x	6.84x	6.32x
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	0x	9.09x	-	-
FCF Yield	-	-	-	-	10.6%	11%	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3666	1.417	1.081	0.658	1.43	1.124	1.214	1.256
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	27.74	28.43	28.6	47.72	68.73	70.85	81.35	85.63
EBITDA ¹	17.59	17.11	17.19	22.43	38.22	41.25	48.49	52.44
EBIT	-	-	-	-	-	-	-	-
Net income ¹	9.807	36.63	27.55	16.51	37.23	27.7	31.76	32.77
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	1.77	3.84	5.54	14.32	15.06	13.05	13.05	13.05
Nbr of stocks (in thousands)	26,241	25,124	24,022	25,590	25,377	25,415	-	-
Announcement Date	3/17/22	3/16/23	3/14/24	3/18/25	3/12/26	-	-	-